Filter
8926
Filtered Results: 8926
Text search:
infectious
disease
control
Featured
Recommendations
943
New Publications
2112
Language
Document type
No document type
4252
Guidelines
1562
Studies & Reports
1481
Manuals
487
Strategic & Response Plan
366
Fact sheets
320
Training Material
154
Situation Updates
92
Infographics
71
Resource Platforms
57
Online Courses
36
Brochures
30
Videos
13
App
5
Countries / Regions
Global
400
India
388
Kenya
221
Sierra Leone
213
Liberia
192
South Africa
182
Africa
171
Nigeria
165
Western and Central Europe
162
Ethiopia
158
Latin America and the Carribbean
157
Uganda
146
Congo, Democratic Republic of
130
Nepal
124
Tanzania
123
Rwanda
120
Malawi
105
Zambia
99
West and Central Africa
91
Ghana
88
Guinea
88
Bangladesh
87
Namibia
79
Russia
78
Syria
76
Mozambique
75
East and Southern Africa
74
Senegal
73
Myanmar / Burma
73
Middle East and North Africa
68
Brazil
67
Philippines
66
Ukraine
63
Haiti
62
South–East Asia Region
58
Eastern Europe
56
Zimbabwe
55
South Sudan
54
Asia
48
Burkina Faso
47
Germany
46
Colombia
43
Lesotho
43
Cambodia
42
Cameroon
40
Yemen
39
Eastern Europe and Central Asia
36
Indonesia
36
Angola
32
Côte d’Ivoire / Ivory Coast
30
Mali
30
Venezuela
26
Madagascar
25
Paraguay
24
Botswana
23
Eswatini/ Swaziland
22
Guinea-Bissau
21
Pakistan
21
Western Pacific Region
20
Benin
19
Vietnam
18
Central African Republic
18
China
17
Afghanistan
17
Peru
17
USA
17
Bolivia
17
Argentina
17
Spain
16
Tajikistan
13
Thailand
13
Albania
13
Sudan
13
Somalia
13
Togo
12
Chad
12
Ecuador
12
Niger
10
Jordan
10
North America
10
Iraq
10
Chile
9
Laos
9
Burundi
9
Moldova
9
Sri Lanka
9
Georgia
9
Lebanon
8
North Macedonia
7
Timor Leste/ East Timor
7
Turkey
7
Saudi Arabia
7
France
7
Portugal
7
Papua New Guinea
7
Iran
6
Italy
6
Honduras
6
Mexico
5
El Salvador
5
Armenia
5
Palestine
5
Bhutan
5
Canada
4
Japan
4
United Kingdom
4
Southern Africa
4
Egypt
4
Serbia
3
Gambia
3
Fiji
3
Singapore
3
Congo-Brazzaville
3
Uzbekistan
3
Malaysia
3
Dominican Republic
3
Turkmenistan
3
Mauritius
3
Djibouti
3
Romania
3
Poland
3
Libya
3
North Korea
2
Switzerland
2
Estonia
2
Kyrgyzstan
2
Qatar
2
Bulgaria
2
Hungary
2
Gabon
2
Uruguay
2
Belgium
2
Tunisia
2
Nicaragua
2
Greece
2
Guatemala
2
Australia
1
Kazakhstan
1
Austria
1
Morocco
1
Mongolia
1
Mauritania
1
Cape Verde
1
Lithuania
1
Ireland
1
Denmark
1
Maldives
1
South Korea
1
Morocco
1
Azerbaijan
1
Belarus
1
Israel
1
Latvia
1
Belize
1
Costa Rica
1
Guyana
1
Oman
1
Panama
1
Slovakia
1
Authors & Publishers
Publication Years
Category
Countries
3238
Clinical Guidelines
756
Public Health
431
Key Resources
428
Women & Child Health
348
Capacity Building
166
Pharmacy & Technologies
121
Annual Report MEDBOX
2
Toolboxes
COVID-19
1256
HIV
713
TB
647
Ebola & Marburg
472
NTDs
436
AMR
381
Mental Health
295
Planetary Health
248
Rapid Response
234
Malaria
218
Caregiver
215
Cholera
172
NCDs
146
Zika
135
Conflict
133
Refugee
121
Pharmacy
121
2.0 Rapid Response
114
Global Health Education
111
Disability
86
Health Financing Toolbox
80
Natural Hazards
79
Polio
53
Specific Hazards
37
Social Ethics
11
Typhoon
3
South Sudan
2
The Cholera Q&A Fact Sheet provides essential information about cholera, including its causes, symptoms, treatment, and prevention. Cholera is an acute diarrheal disease caused by Vibrio cholerae, which spreads through contaminated water and food. It leads to rapid dehydration and can be fatal if un...
These Frequently Asked Questions (FAQs) have been developed by the Infant Feeding in Emergencies (IFE) Core Group Infectious Disease Working Group based on the most recent recommendations, collective knowledge and evidence on cholera. The FAQs also draw on infant and young child feeding (IYCF) recom...
Ebola interventions: The intervention to combat Ebola aims to stop human-to-human transmission. The package is composed of five elements necessary to control the spread of the disease: care to patients, contact monitoring, safe burials, laboratory support and social mobilisation.
The document al...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development of resistance is caused by the...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
En los últimos decenios se han logrado avances significativos en el control de la esquistosomiasis así como de las geohelmintiasis, y la OMS ha trazado una hoja de ruta para guiar la aplicación de las políticas y las estrategias planteadas en Accelerating work to overcome the global impact of ne...
The school and a community teaching modules are aimed at preventing vector-borne diseases through community participation. Meanwhile, the interactive toolkit is meant to be help raise awareness on health, sanitation and vector control. These materials will help volunteers and practitioners foster di...
Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease. Infection occurs when filarial parasites are transmitted to humans through mosquitoes. When a mosquito with infective stage larvae bites a person, the parasites are deposited on the person’s skin from where the...
In the battle against diseases like Zika and dengue, knowledge is power. Climate change is shifting the
distribution of mosquitoes and to new areas. Empowering communities is essential in reaching and pro-
tecting the most vulnerable individuals and households. Vector control programmes, community...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)...
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe...
28 May 2021
Contact tracing is a key component of a public health response to infectious disease outbreaks. The purpose of this guidance is to reinforce the place of community engagement and participation in the contact tracing process. The guidance and related products articulate best practice pri...
Namibia is estimated to be at 94-97-93 as defined by the UNAIDS 95-95-95 treatment cascade, one of the first high burden countries to approach epidemic control. COP22 is about sustaining the impact of years of investment and partnership with the Namibian government and other stakeholders by employin...
Strengthening global health security to protect the world against future epidemics and pandemics requires well-tested and decentralized capacities for the local detection and rapid containment of outbreaks of infectious disease. For such capacities to translate into effective response actions, ind...
The COVID-19 pandemic is rapidly spreading across the world and including countries affected by other infectious disease epidemics, such as HIV, tuberculosis (TB) and malaria. Over the past three decades, the global HIV response has gained experience in developing effective prevention approaches. Th...
Viral hepatitis is defined as inflammation of the liver cells due to viral infection. The burden of liver disease in South Africa is mostly underestimated as viral hepatitis, in particular chronic infection, is a silent and neglected cause of morbidity and mortality. However, the burden of disease i...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
Lateral-flow rapid diagnostic tests (RDTs) continue to play a vital role in global health in the management and diagnosis of infectious diseases, including malaria, HIV and COVID-19. Visually interpreted RDTs, more than any other class of diagnostics, fulfil WHO’s ASSURED criteria,1 enabling their...
